Immunological Trajectory of HIV Patients on ۴-Year Antiretroviral Therapy: A ۱۳-Year Observational Study from Khorramabad

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: فارسی
مشاهده: 27

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_BJM-15-59_004

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Introduction: The gradual decline in CD۴+ T-cell counts following HIV infection leads to impaired immune function and serves as a primary determinant of the clinical course in HIV-infected patients. Antiretroviral therapy increases CD۴+ lymphocyte counts, thereby enhancing immunity and reducing opportunistic infections and mortality. This study aimed to investigate the effect of three-drug antiretroviral regimens on CD۴+ cell counts in HIV-infected patients in Khorramabad. In this observational cohort study, data from ۲۴۲ HIV-infected patients receiving either NNRTI-based (n=۱۸۱) or INSTI-based (n=۶۱) regimens were analyzed. CD۴+ T-cell counts were measured at baseline and at ۶ months, ۱, ۲, ۳, and ۴ years post-treatment initiation. Generalized Estimating Equations (GEE) models were used to evaluate longitudinal changes in absolute CD۴+ T-cell counts, and an independent t-test was performed to compare the mean change from baseline between groups. The INSTI-based group had a significantly lower baseline CD۴+ T-cell count compared to the NNRTI-based group (۳۳۱ vs. ۴۵۲ cells/μL). The mean increase in CD۴+ T-cell count from baseline was significantly greater in the INSTI-based group (۴۰۶ cells/μL) compared to the NNRTI-based group (۲۹۹ cells/μL) (P=۰.۰۰۲). However, GEE analysis demonstrated that patients on the NNRTI-based regimen maintained significantly higher absolute CD۴+ T-cell counts throughout follow-up compared to those on the INSTI-based regimen (P<۰.۰۰۱), which likely reflects their higher baseline values. Both regimens were associated with improvements in CD۴+ T-cell counts. The INSTI-based regimen showed a greater mean increase from baseline, while the NNRTI-based regimen maintained higher absolute CD۴+ T-cell counts over time. Due to the observational design, substantial baseline imbalances between groups, and the small sample size in the INSTI group during long-term follow-up, no causal claims of superiority can be made for either regimen. These hypothesis-generating findings require confirmation through randomized controlled trials with balanced baseline characteristics.

نویسندگان

Maryam Hasanpoor

USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran

Kiana Shahzamani

Razi Herbal Medicine Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Somaieh Sabzali

Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran.

Mehdi Birjandi

Department of Nutrition, Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

Tabassom Zavari

Department of Tropical and Infectious Diseases, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :